ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements
Lotus Eye Hospital And Institute Limited held its 29th Annual General Meeting on September 23, 2026, via video conferencing to discuss company operations and financial highlights.
Lotus Eye Hospital and Institute Limited will hold its 29th Annual General Meeting on September 23, 2026. The company has dispatched the Notice and Annual Report for FY 2025-26.
Lotus Eye Hospital and Institute Limited launched 'Lotus Optique', a new optical retail store in Coimbatore. The facility integrates professional eye care with quality eyewear products.
Lotus Eye Hospital and Institute Ltd reported revenue from operations of ₹17.1 Cr (+26.7% YoY) and net profit of ₹0.6 Cr (+20.0% YoY) for Q1 FY27.
Lotus Eye Hospital and Institute will hold a board meeting on August 10, 2026, to approve the company's standalone unaudited financial results for the June quarter.
Lotus Eye Hospital submitted its Annual Secretarial Compliance Report for FY2026. A ₹1.02 Crore fine was paid for delayed shareholder approval regarding a director's appointment.
Lotus Eye Hospital re-appointed Mr. P Vishnu Adithan as Internal Auditor for a twelve-month term. The appointment follows board approval effective from April 1, 2026.
Lotus Eye Hospital and Institute Ltd reported revenue from operations of ₹13.6 Cr (+18.3% YoY) and a net loss of ₹0.3 Cr for Q4 FY26.
Lotus Eye Hospital reported annual total income of ₹54.89 Crore for FY2026. The board also reappointed Mr. P Vishnu Adithan as Internal Auditor for FY2026-27.
Lotus Eye Hospital scheduled a board meeting for May 26, 2026, to approve fiscal year-end financial results. The trading window remains closed for 48 hours post-declaration.
Promoter Sangeetha Sundaramoorthy acquired 14,28,571 shares via an inter-se transfer, increasing her stake to 35.01%. This internal restructuring consolidates promoter-group holding within the company.
Lotus Eye Hospital and Institute Limited confirmed it does not meet the 'Large Corporate' criteria as of March 31, 2026. This disclosure complies with SEBI's framework for fund raising via debt securities by large entities.
Lotus Eye Hospital and Institute Ltd submitted its compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The filing confirms that securities received for dematerialization have been verified, mutilated, and cancelled. This is a routine regulatory disclosure regarding share record maintenance.